Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model

被引:5
|
作者
Porath, Binu [1 ]
Livingston, Safia [2 ]
Andres, Erica L. [2 ]
Petrie, Alexandra M. [2 ]
Wright, Joshua C. [2 ]
Woo, Anna E. [3 ]
Carlton, Carol G. [4 ]
Baybutt, Richard [5 ]
Vanden Heuvel, Gregory B. [2 ,6 ]
机构
[1] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN USA
[2] Wheaton Coll, Dept Biol, Wheaton, IL 60187 USA
[3] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA
[4] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS USA
[5] Wheaton Coll, Dept Appl Hlth Sci, Wheaton, IL 60187 USA
[6] Western Michigan Univ, Dept Biomed Sci, Homer Stryker MD Sch Med, 1000 Oakland Dr, Kalamazoo, MI 49008 USA
关键词
Cux1; polycystic kidney disease; p27; HOMEODOMAIN PROTEIN CUX1; CYST FORMATION; MICE LACKING; CUT HOMEODOMAIN; MULTIORGAN HYPERPLASIA; P27(KIP1) EXPRESSION; DOWN-REGULATION; CPK MICE; GROWTH; PKD1;
D O I
10.1152/ajprenal.00380.2016
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common monogenic hereditary disorders in humans characterized by fluid-filled cysts, primarily in the kidneys. Cux1, a cell cycle regulatory gene highly expressed during kidney development, is elevated in the cyst-lining cells of Pkd1 mutant mice, and in human ADPKD cells. However, forced expression of Cux1 is insufficient to induce cystic disease in transgenic mice or to induce rapid cyst formation after cilia disruption in the kidneys of adult mice. Here we report a double mutant mouse model that has a conditional deletion of the Pkd1 gene in the renal collecting ducts together with a targeted mutation in the Cux1 gene (Pkd1(CD); Cux1(tm2Ejn)). While kidneys isolated from newborn Pkd1(CD) mice exhibit cortical and medullary cysts, kidneys isolated from newborn Pkd1CD; Cux1(tm2Ejn-/-) mice did not show any cysts. Because Cux1(tm2Ejn-/-) are perinatal lethal, we evaluated Pkd1(CD) mice that were heterozygote for the Cux1 mutation. Similar to the newborn Pkd1CD; Cux1(tm2Ejn-/-) mice, newborn Pkd1(CD); Cux1(tm2Ejn-/-) mice did not show any cysts. Comparison of Pkd1(CD) and Pkd1(CD); Cux1(tm2Ejn-/-) mice at later stages of development showed a reduction in the severity of PKD in the Pkd1(CD); Cux1(tm2Ejn-/-) mice. Moreover, we observed an increase in expression of the cyclin kinase inhibitor p27, a target of Cux1 repression, in the rescued collecting ducts. Taken together, our results suggest that Cux1 expression in PKD is not directly involved in cystogenesis but promotes cell proliferation required for expansion of existing cysts, primarily by repression of p27.
引用
收藏
页码:F1050 / F1059
页数:10
相关论文
共 50 条
  • [41] A study of sirolimus and mTOR kinase inhibitor in a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease
    Holditch, Sara J.
    Brown, Carolyn N.
    Atwood, Daniel J.
    Lombardi, Andrew M.
    Nguyen, Khoa N.
    Toll, Harrison W.
    Hopp, Katharina
    Edelstein, Charles L.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2019, 317 (01) : F187 - F196
  • [42] Pathogenic sequence for dissecting aneurysm formation in a hypomorphic polycystic kidney disease 1 mouse modelle
    Hassane, Sabrine
    Claij, Nanna
    Lantinga-van Leeuwen, Irma S.
    Van Munsteren, J. Conny
    Van Lent, Natascha
    Hanemaaijer, Roeland
    Breuning, Martijn H.
    Peters, Dorien J. M.
    DeRuiter, Marco C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (10) : 2177 - 2183
  • [43] Cathepsin L promotes ionizing radiation-induced U251 glioma cell migration and invasion through regulating the GSK-3β/CUX1 pathway
    Fei, Yao
    Xiong, Yajie
    Shen, Xiao
    Zhao, Yifan
    Zhu, Ying
    Wang, Long
    Liang, Zhongqin
    CELLULAR SIGNALLING, 2018, 44 : 62 - 71
  • [44] CTGF Is Expressed During Cystic Remodeling in the PKD/Mhm (cy/ plus ) Rat Model for Autosomal-Dominant Polycystic Kidney Disease (ADPKD)
    Gauer, Stefan
    Holzmann, Yvonne
    Kraenzlin, Bettina
    Hoffmann, Sigrid C.
    Gretz, Norbert
    Hauser, Ingeborg A.
    Goppelt-Struebe, Margarete
    Geiger, Helmut
    Obermueller, Nicholas
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2017, 65 (12) : 743 - 755
  • [45] VX-809 mitigates disease in a mouse model of autosomal dominant polycystic kidney disease bearing the R3277C human mutation
    Yanda, Murali K.
    Cebotaru, Liudmila
    FASEB JOURNAL, 2021, 35 (11)
  • [46] Hypermethylation Of ADHFE1 Promotes The Proliferation Of Colorectal Cancer Cell Via Modulating Cell Cycle Progression
    Hu, Yu-Han
    Ma, Shuai
    Zhang, Xiang-Nan
    Zhang, Zhe-Ying
    Zhu, Hui-Fang
    Ji, Ying-Hua
    Li, Jian
    Qian, Xin-Lai
    Wang, Yong-Xia
    ONCOTARGETS AND THERAPY, 2019, 12 : 8105 - 8115
  • [47] Chronic treatment with tempol does not significantly ameliorate renal tissue hypoxia or disease progression in a rodent model of polycystic kidney disease
    Ding, Alice
    Kalaignanasundaram, Priyadharshani
    Ricardo, Sharon D.
    Abdelkader, Amany
    Witting, Paul K.
    Broughton, Brad R. S.
    Kim, Hyun B.
    Wyse, Benjamin F.
    Phillips, Jacqueline K.
    Evans, Roger G.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2012, 39 (11) : 917 - 929
  • [48] Increased mTOR and suppressed autophagic flux in the heart of a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease
    Atwood, Daniel J.
    Pokhrel, Deepak
    Brown, Carolyn N.
    Holditch, Sara J.
    Bachu, Dheevena M.
    Thorburn, Andrew
    Hopp, Katharina
    Edelstein, Charles L.
    CELLULAR SIGNALLING, 2020, 74
  • [49] Overexpression of DJ-1 alleviates autosomal dominant polycystic kidney disease by regulating cell proliferation, apoptosis, and mitochondrial metabolism in vitro and in vivo
    Li, Zhongxin
    Zhou, Jingjing
    Li, Yan
    Yang, Fan
    Lian, Xiaoying
    Liu, Wenhu
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (18)
  • [50] miR-25-3p promotes proliferation and inhibits autophagy of renal cells in polycystic kidney mice by regulating ATG14-Beclin 1
    Liu, Guojian
    Kang, Xiaowen
    Guo, Ping
    Shang, Yu
    Du, Ruomei
    Wang, Xiyue
    Chen, Liting
    Yue, Rui
    Kong, Fanwu
    RENAL FAILURE, 2020, 42 (01) : 333 - 342